Longer lead time was needed for minimum stock requirements

Stakeholders believe the government should have given pharmaceutical companies an 18 to 24-month window to comply with minimum stock requirements  Data from the Review of the Minimum Stockholding Requirements - Early review of the 12-month progress and outcomes report found that less than half (45%) of designated brands were compliance with the requirements throughout the first